TECHNICAL UNIVERSITY
IN LODZ
&
BIOVALLEY
COOPERATIVE
care for the world
begins with
care for human
Sustainable
Personal Protective Clothing
for Healthcare Applications
INNOVATION TEXTILE BIOTECHNOLOGY
MICROBIOLOGICALLY
SELF-CLEANING NONWOVEN
BIODEGRADABLE
PROBLEM IN HOSPITALS
DISEASE TRANSMISSION & INFECTIONS
2
Cotton workwear, especially in hospitals, is a still breeding
ground for pathogens and a source of their transmission
between patients and medical staff.
The only way to protect people in hospitals is to wash cotton
clothes daily. However, there are many risks in this
procedure, the violation of which can lead to nosocomial
infections, e.g. SEPSA.
The risks include:
•Textiles contamination during washing and ironing
•Environment pollution of by aggressive agents for washing
•Textiles contamination during packaging, transport
SOLUTION
biodegaradble bioactive nonwoven
3
+
Nonwoven material
Natural fibres
Biopolymer composite
based on chitosan
Bioactive non-woven
(biodegradable)
=Phatogen-free
skin
textiles
textiles
Biocidal nonwoven 4
raw nonwoven
Photos made in laboratory in ITEE Lukasiewicz Research Network in microscope technology SEM + EDS
biocidal nonwoven with natural polymer composite
Photos made in laboratory in ITEE Lukasiewicz Research Network in microscope technology SEM + EDS
5
MECHANISMS
OF BIONWOVEN
BIOCIDAL ACTIVITIES
FOR VIRUSES
FOR BACTERIAS
Research results
bioactivity & durability 6
Tested samples
Viral
titer
after
2h incubation
Reduction of
virus
logTCID50 %
T1 bioactive
tested by
Human
influenzavirus A/H1N1
(ATCC
-VR-1469)
0.5 99,93
T2 bioactive
tested by
Human
influenzavirus A/H1N1 1.72 99
tested samples
assessment of
bacterial growth
under the sample
Effect of
T1 bioactive
tested by
esterichia coli (ATCC 11 229)
Lack of growth Good effect
T2 bioactive tested by
staphylococcus Aureus
(ATCC 6538)
Lack of growth Good effect
Laboratory of Lukasiewicz Institute PCA no AB388
Standard PN-EN ISO 20645 : 2006
Laboratory of Institute IET Polish Academy of Science
Standard ISO 18184 : 2019
tested samples took
from the same materiał
Effect of
May 2022
Effect of November
2022 (after 6 months)
T
1, T3 bioactive tested by
Escherichia coli (ATCC 11
229)
Good effect
Sample T1
Good effect
Sample T3
T2, T4
bioactive tested by
S
taphylococcus Aureus
(ATCC 6538)
Good effect
Sample T2
Good effect
Sample T4
Laboratory of Lodz University of Technology
Standard PN-EN ISO 20645 : 2006
Test report of
18.01.2022
Sample no
Gram-
negative
bacteria
Gram-positive
bacteria
fungi
Yeast Molds
Escherichia
coli
Staphyloco
ccus
aureus
Bacillus
subtilis
Candida
mycoderma
Aspergillus
niger
4++ ++ +++ ++ ++
6+++ +++ +++ +++ +++
Institute of FT&M Lodz University of Technology
standard PN-EN ISO 20645:2006 for bacterias & PN-EN ISO 14119:2005 for fungi
Assessment of antimicrobial activity of tested textile materials
INTERNATIONAL AWARDS 7
World Invention Intellectual
Property Associations
TAIWAN
1-3 December, 2022
National Research
Council of Thailand
BANGKOK
1-6 February, 2023
The First Institute of Researchers
and Inventors in I.R Iran
BANGKOK
1-6 February, 2023
The invention submitted by the Technical University like co-owner
at international exhibitions of inventions won prestigious awards
www.biovalley,org,pl
The International
Exhibition of Inventions
Geneva
17-21 April , 2023
8
ECONOMY
Cheaper than existing solutions
Saves medical costs
Value for the health system
ECOLOGY
Biodegradable
Low coal & water footprints
Green hospitals
ERGONOMY
Standard compliant
Comfortable for users
Non-allergenic ingredients
EPIDEMIOLOGY
Infection prevention
Material free from pathogens
Hospital wasteless
www.biovalley,org,pl ADVANTAGES
of innovation material
9
ENVIROMENT
Renewable raw materials
No waste
Water Saving
HOSPITALS
hospitals textiles lower costs
reduction of treatment cost
"Green Hospitals”
SOCIETY
Infection reduction
Reduction of deaths
Sanitary safety
PRODUCER
Innovative technology
Economic efficiency
Fast growing unicorn
Multidimensional benefits
11
PURPOSE OF USE OF BIOMATERIAL
IN HEALTH CARE SYSTEMS
www.biovalley,org,pl
1.PATIENTS PROTECTION AGAINST HOSPITAL ACQUIRED INFECTIONS
2.PREVENTING EPIDEMICS IN REFUGEE CAMPS
3.PREVENTING INFECTIONS DURING VETERINARY TREATMENTS
4.PREVENTING INFECTIONS IN ANIMAL FARMS
5.PREVENTING INFECTIONS DURING LONG-DISTANCE TRIPS
6.PROFITS FOR PATIENTS: LOWER RISK OF DIE BECAUSE OF HAI’s,
7.PROFITS FOR HOSPITALS: LOWER COSTS OF TREATMENT AND COMPENSATION, LOWER
COSTS OF HOSPITAL SANITARY PROCEDURES, LOWER COSTS OF MEDICAL CLOTHES&
TEXTILES
8.PROFIT FOR ENVINROMENT: WATERLESS AND WASTELESS BIOTECHNOLOGY
OWNERS
OF WORLD PATENTED INVENTION
BIOVALLEY COOPERATIVE
TECHNOLOGY PARTNER
TECHNICAL UNIVERSITY
SCIENCE PARTNER
12
DESIGNER, MANUFACTURER
IMPLEMENTER, FUNDER
COORDINATOR R&D
KNOW HOW TECHNOLOGICAL
FORMULA DEVELOPMENT
R&D PLANER, FUNDER
LABORATORY WORKS
RESEARCH WORKS
MICROBIAL SELF-CLEANING NONWOVEN
WITH ANTYBACTERIA, ANTYFUNGY & ANTYVIRAL ACTIVITIES
www.biovalley,org,pl
4th June 2023
date of PCT granting
the global protection by
10th October 2023
date of patent granting
the polish market by
SCIENCE
PRODUCT
TECHNOLOGY RESEARCH
OUR INNOVATIONS:
PROTECT PEOPLE
SAVE ENVIRONMENT
BRING SCIENCE TO MARKET
13
WE CHANGE THE WORLD FOR THE BETTER
Margarita
Haller de Hallenburg,
INNOVATOR, INVENTOR, FOUNDER
m.haller@biovalley.pl
+48 536 410 900
